Published in:
Open Access
01-12-2011 | Short report
Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
Authors:
Ana Leda F Longhini, Felipe von Glehn, Carlos Otávio Brandão, Rosemeire FO de Paula, Fernando Pradella, Adriel S Moraes, Alessandro S Farias, Elaine C Oliveira, Juan G Quispe-Cabanillas, Cassiana Horta Abreu, Alfredo Damasceno, Benito P Damasceno, Konstantin E Balashov, Leonilda MB Santos
Published in:
Journal of Neuroinflammation
|
Issue 1/2011
Login to get access
Abstract
The plasmacytoid dendritic cells (pDCs) express a high level of Toll-like receptor 9 (TLR-9), which recognizes viral DNA. Activated via TLR-9, pDCs also secrete large amounts of type I interferon which are involved either in stimulation or down regulation of immune response in multiple sclerosis (MS). In the present study, we determinate pDCs levels by flow cytometry in Cerebrospinal Fluid (CSF) and Peripheral Blood from MS patients in relapsing and in remitting phases of the disease, comparing with other non-inflammatory diseases (OND). We provide evidence that MS patients in relapse without any treatment have a significantly (p < 0.01) higher percentage of pDCs in CSF than do patients in remission or those with OND. No change in the percentage of pDCs was observed in the peripheral blood of any of these patients. The increase of pDCs in central nervous system during relapse may be explained either by a virus infection or a down regulatory process.